5-Bromo-2-Chloro-4′-Ethoxydiphenylmethane CAS 461432-23-5 Dapagliflozin Intermedia Factory
Manufacturer Supple, Puritas, Commercial Productio
Dapagliflozin (CAS: 461432-26-8) Intermedia:
5-Bromo-2-Chlorobenzoicum Acidum CAS 21739-92-4
5-Bromo-2-Chloro-4'-Ethoxydiphenylmethane CAS 461432-23-5
2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone CAS 32384-65-9
| Nomen chemicum | 5-Bromo-2-Chloro-4'-Ethoxydiphenylmethane |
| Synonyma | 4-Bromo-1-Chloro-2-(4-Ethoxybenzyl)benzene;4-(5-Brom-2-Chlorbenzyl)phenyl-Ethylether;Dapagliflozin Bromo Impurity |
| CAS Number | 461432-23-5 |
| CATTUS Number | RF-PI447 |
| Stock Status | In Stock, Productio Ascendite ad Tons |
| Formulae hypotheticae | C15H14BrClO |
| M. Pondus | 325.63 |
| Liquescens punctum | 41.0 ad 43.0℃ |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | Alba ad Pael Yellow Crystallina pulveris |
| Puritas / Analysis Methodus | ≥99.0% (HPLC) |
| Aquae (KF) | ≤0.50% |
| Totalis immunditias | ≤1.0% |
| Test Standard | Enterprise Standard |
| Consuetudinem | Medium Dapagliflozin (CAS: 461432-26-8), typus II diabete |
sarcina: Utrem, aluminium foil, pera, cardboard Drum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;A luce et humore protege.
4-Bromo-1-Chloro-2-(4-Ethoxybenzyl)benzene (CAS: 461432-23-5) ponitur ut medius in synthesi Dapagliflozin (CAS: 461432-26-8).Dapagliflozin potens est, selectivum renum sodium-dependens glucosium cotransportator 2 (SGLT2) inhibitor ad tractationem speciei 2 diabete.Dapagliflozin novum medicamentum antidiabeticum coniunctim a Bristol-Myers Squibb et AstraZeneca evolvit, probatum ab Europaeis medicinis Agency (EMA) die 12 Novembris 2012. Kalendis Ianuariis MMXIV, US Cibus et Administration (FDA) approbavit. in tractatione diabete generis II adhibita.
